206 related articles for article (PubMed ID: 32422568)
21. An induced pluripotent stem cell line (YCMi006-A) generated from a patient with hypertrophic cardiomyopathy who carries the ACTA1 mutation p.Ile343Met.
Kim H; Kim HJ; Oh J; Lee ST; Won D; Choi HK; Choi JR; Kim S; Kim HP; Kim SJ; Park SW; Kang SM; Lee SH
Stem Cell Res; 2022 Aug; 63():102874. PubMed ID: 35917599
[TBL] [Abstract][Full Text] [Related]
22. A heterozygous MYBPC3 (c. 772+1G > A) mutant human induced pluripotent stem cell line (ZZUNEUi025-A) generated from a male patient with hypertrophic cardiomyopathy.
Zhao X; Cao J; Li X; Liu M; Liu Y; Dong J; Zhao X
Stem Cell Res; 2022 Apr; 60():102722. PubMed ID: 35257994
[TBL] [Abstract][Full Text] [Related]
23. Hypertrophic cardiomyopathy
Rose J; Kraft T; Brenner B; Montag J
Physiol Genomics; 2020 Jan; 52(1):15-19. PubMed ID: 31790337
[TBL] [Abstract][Full Text] [Related]
24. Successful knock-in of Hypertrophic Cardiomyopathy-mutation R723G into the MYH7 gene mimics HCM pathology in pigs.
Montag J; Petersen B; Flögel AK; Becker E; Lucas-Hahn A; Cost GJ; Mühlfeld C; Kraft T; Niemann H; Brenner B
Sci Rep; 2018 Mar; 8(1):4786. PubMed ID: 29555974
[TBL] [Abstract][Full Text] [Related]
25. Multiplexed Functional Assessments of
Friedman CE; Fayer S; Pendyala S; Chien WM; Loiben A; Tran L; Chao LS; McKinstry A; Ahmed D; Farris SD; Stempien-Otero A; Jonlin EC; Murry CE; Starita LM; Fowler DM; Yang KC
Circ Genom Precis Med; 2024 Apr; 17(2):e004377. PubMed ID: 38362799
[TBL] [Abstract][Full Text] [Related]
26. Abnormal calcium handling properties underlie familial hypertrophic cardiomyopathy pathology in patient-specific induced pluripotent stem cells.
Lan F; Lee AS; Liang P; Sanchez-Freire V; Nguyen PK; Wang L; Han L; Yen M; Wang Y; Sun N; Abilez OJ; Hu S; Ebert AD; Navarrete EG; Simmons CS; Wheeler M; Pruitt B; Lewis R; Yamaguchi Y; Ashley EA; Bers DM; Robbins RC; Longaker MT; Wu JC
Cell Stem Cell; 2013 Jan; 12(1):101-13. PubMed ID: 23290139
[TBL] [Abstract][Full Text] [Related]
27. Symptomatic distal myopathy with cardiomyopathy due to a MYH7 mutation.
Overeem S; Schelhaas HJ; Blijham PJ; Grootscholten MI; ter Laak HJ; Timmermans J; van den Wijngaard A; Zwarts MJ
Neuromuscul Disord; 2007 Jun; 17(6):490-3. PubMed ID: 17383184
[TBL] [Abstract][Full Text] [Related]
28. A novel mutation of the MYH7 gene in a patient with hypertrophic cardiomyopathy.
Goel N; Huddleston CB; Fiore AC
Turk J Pediatr; 2018; 60(3):315-318. PubMed ID: 30511546
[TBL] [Abstract][Full Text] [Related]
29. Hypertrophic cardiomyopathy clinical phenotype is independent of gene mutation and mutation dosage.
Viswanathan SK; Sanders HK; McNamara JW; Jagadeesan A; Jahangir A; Tajik AJ; Sadayappan S
PLoS One; 2017; 12(11):e0187948. PubMed ID: 29121657
[TBL] [Abstract][Full Text] [Related]
30. Generation of an induced pluripotent stem cell line (SYSUi005-A) from a patient with hypertrophic cardiomyopathy.
Zhang C; Shi J; Zhang Z; Zhao Q; Xie M; Chen Y; Xiang Q
Stem Cell Res; 2022 Jan; 58():102626. PubMed ID: 34942479
[TBL] [Abstract][Full Text] [Related]
31. Generation of an iPSC line (ZZUNEUi021-A) from a hypertrophic cardiomyopathy patient with TNNT2 mutation.
Dong Y; Li X; Fu W; Tian X; Guo G; Peng Y; Zhai Y; Zhao J; Ding Z; Zhao X; Dong J
Stem Cell Res; 2022 Jan; 58():102622. PubMed ID: 34929444
[TBL] [Abstract][Full Text] [Related]
32. Cranial, axial and proximal myopathy and hypertrophic cardiomyopathy caused by a mutation in the globular head region of the MYH7 gene.
Díaz-Manera J; Alejaldre A; Llauger J; Mirabet S; Rojas-García R; Ramos-Fransi A; Gallardo E; Illa I
Eur J Neurol; 2014 Jun; 21(6):e51-2. PubMed ID: 24805292
[No Abstract] [Full Text] [Related]
33. End-stage Hypertrophic Cardiomyopathy with Advanced Heart Failure in Patients Carrying MYH7 R453 Variants: A Case Series.
Naito S; Higo S; Kameda S; Ogawa S; Tabata T; Akazawa Y; Nakamura D; Nakamoto K; Sera F; Kuramoto Y; Asano Y; Hikoso S; Miyagawa S; Sakata Y
Intern Med; 2023 Nov; 62(21):3167-3173. PubMed ID: 36948619
[TBL] [Abstract][Full Text] [Related]
34. Intrinsic MYH7 expression regulation contributes to tissue level allelic imbalance in hypertrophic cardiomyopathy.
Montag J; Syring M; Rose J; Weber AL; Ernstberger P; Mayer AK; Becker E; Keyser B; Dos Remedios C; Perrot A; van der Velden J; Francino A; Navarro-Lopez F; Ho CY; Brenner B; Kraft T
J Muscle Res Cell Motil; 2017 Aug; 38(3-4):291-302. PubMed ID: 29101517
[TBL] [Abstract][Full Text] [Related]
35. Presence of Hypertrophic Cardiomyopathy Related Gene Mutations and Clinical Manifestations in Vietnamese Patients With Hypertrophic Cardiomyopathy.
Tran Vu MT; Nguyen TV; Huynh NV; Nguyen Thai HT; Pham Nguyen V; Ho Huynh TD
Circ J; 2019 Aug; 83(9):1908-1916. PubMed ID: 31308319
[TBL] [Abstract][Full Text] [Related]
36. [The role of three-dimensional speckle tracking imaging derived parameters on predicting outcome of hypertrophic cardiomyopathy patients with MYH7 mutations].
Zhao J; Wang J; Liu LW; Zheng Y; Wang B; Li WX; Yang F; Kang N; Zuo L
Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Apr; 48(4):287-293. PubMed ID: 32370479
[No Abstract] [Full Text] [Related]
37. A Contraction Stress Model of Hypertrophic Cardiomyopathy due to Sarcomere Mutations.
Cohn R; Thakar K; Lowe A; Ladha FA; Pettinato AM; Romano R; Meredith E; Chen YS; Atamanuk K; Huey BD; Hinson JT
Stem Cell Reports; 2019 Jan; 12(1):71-83. PubMed ID: 30554920
[TBL] [Abstract][Full Text] [Related]
38. Generation of an induced pluripotential stem cell (iPSC) line from a patient with hypertrophic cardiomyopathy carrying myosin binding protein C (MYBPC3) c.3369-3370 insC mutation.
Jin J; Lu L; Chen J; Wang K; Han J; Xue S; Weng G
Stem Cell Res; 2020 Dec; 50():102144. PubMed ID: 33388705
[TBL] [Abstract][Full Text] [Related]
39. Clinical outcomes associated with sarcomere mutations in hypertrophic cardiomyopathy: a meta-analysis on 7675 individuals.
Sedaghat-Hamedani F; Kayvanpour E; Tugrul OF; Lai A; Amr A; Haas J; Proctor T; Ehlermann P; Jensen K; Katus HA; Meder B
Clin Res Cardiol; 2018 Jan; 107(1):30-41. PubMed ID: 28840316
[TBL] [Abstract][Full Text] [Related]
40. Generation of an induced pluripotent stem cell line from a hypertrophic cardiomyopathy patient with a pathogenic myosin binding protein C (MYBPC3) p.Arg502Trp mutation.
Holliday M; Ross SB; Lim S; Semsarian C
Stem Cell Res; 2018 Dec; 33():56-59. PubMed ID: 30316040
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]